Elaia Partners

Fiche investisseur | Builders Republic

À propos

Elaia is one of the most scientific and "Deeptech" focused Venture Capital firms in Europe. Founded in 2002, it is a historical player that has shifted heavily towards bridging the gap between academic research and business. Elaia differentiates itself by embedding itself directly into the research ecosystem: they have exclusive partnerships with PSL University (Paris Sciences & Lettres) and Inria (National Institute for Research in Digital Science and Technology) to spot innovations before they even leave the lab. While they have a strong digital/SaaS practice, their "superpower" is turning complex science (Quantum, Biotech, AI infrastructure) into global companies.

Informations clés

Type
Venture Capital
Stades
Pre-Seed,Seed,Series A,Series B
Secteurs
Deeptech,Biotech,Climate / Cleantech / Greentech,Data & Infrastructure,Cyber & Security,AI & Automation,Digital health,Fintech & Insurtech,Future of work / HR,Software / SaaS,Business management software,Life sciences,Healthcare,Quantum
Siège
France
Bureaux
Paris,Barcelona,Tel Aviv
Focus géographique
France,Europe,Israel
Lead / Follow
Lead / co-lead
Ticket
0.3M€ – 15M€
Actifs sous gestion
850M€
Fondé en
2002

Track Record

  • Sociétés en portefeuille : 140
  • Investissements totaux : 207
  • Exits : 46
  • Unicorns : 3

Investissements notables en France

Criteo, Mirakl, Ornikar, Shift Technology, Alice & Bob, Aquemia, Ibanfirst, Sonio, ...

Points différenciants

Strong Track Record,Deeptech Specialist,Multi-stage,Corporate-backed